The Defense Threat Reduction Agency (DTRA) awarded a $200,000 Project Grant under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program to the Massachusetts Institute of Technology (MIT) on February 26, 2025. The grant will fund research to discover highly stable materials for adsorption and catalytic decontamination, supporting the advancement of fundamental knowledge and understanding of materials science related to countering chemical, biological, radiological,...
The federal Project Grant award HDTRA12510007 for $631,742, awarded by the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program, aims to develop color-changing coatings for the selective detection of vesicants (chemical warfare agents). The primary objective is to create biomanufactured enzymes that recognize small molecules modified by vesicants and integrate them with signaling agents that produce visible color...
This Project Grant from the Defense Threat Reduction Agency provides $668,000 in funding under the Scientific Research - Combating Weapons of Mass Destruction federal grant program (CFDA 12.351) to support fundamental research to counter weapons of mass destruction. Specifically, the University of California, Berkeley will utilize molecular dynamics simulations to understand how random heteropolymers arrange within and around metal organic frameworks and provide functions such as stabilizing...
The Defense Threat Reduction Agency (DTRA) awarded a $481,680 Project Grant under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) federal grant program to the Puerto Rico Science, Technology, and Research Trust (PRSTRT), a minority-owned non-profit organization. The objective of the 5-year grant, awarded on May 1, 2025, is to develop methods to facilitate the quick identification of natural products in extracts and the quick identification of human protein...
This $603,665 Project Grant award from the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program supports research to develop fluorescence-based sensors for detecting vesicant chemical warfare agents on surfaces. The primary awardee, The Washington University, is conducting this research in collaboration with a sub-awardee, Georgia Tech Research Corporation. The key objectives are to: 1) develop self-immolative...
This federal Project Grant award of $436,200.00 from the Department of the Army Materiel Command Research Development and Engineering Command (RDECOM) under the Department of Defense Basic Scientific Research program (CFDA 12.431) supports research on "Mechanistic Studies of Heterogeneous Chemical Warfare Agent Degradation Catalysts Enabled by Benchtop X-Ray Spectroscopy Suite" to be conducted by Virginia Polytechnic Institute & State University (Virginia Tech). The award, with a...
This Project Grant award from the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program supports research by Michigan State University to develop a novel virus imaging platform using hyperspectral imaging pump-probe techniques. The $500,000 award, granted on April 28, 2025, aims to create a transformative capability for researching medical countermeasures against biological threat agents. The research will leverage...
The Defense Threat Reduction Agency (DTRA) awarded a $100,000 Project Grant under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program to Virginia Polytechnic Institute & State University (Virginia Tech) on February 5, 2025. The grant, titled "Utilizing Complementary Proteomic Approaches to Identify Conserved Host Responses During Infection of Emerging Viruses," aims to advance scientific knowledge and capabilities for defending against chemical,...
This $500,000 Project Grant awarded by the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program supports the development of human-based, connected multi-organ microphysiological system in vitro models to study alphavirus infection and support countermeasure development. The grant was awarded to George Mason University on July 31, 2024 and has a performance period through July 30, 2029. The research aims to advance...
This federal Project Grant award of $175,805.00 was made on August 1, 2024 by the U.S. Department of Defense Research Development and Engineering Command under the Basic Scientific Research program (CFDA 12.431). The grant supports foundational and applied research across diverse scientific and technical domains critical to national security, including areas such as quantum computing, artificial intelligence, materials science, and defense technologies. The primary awardee, Massachusetts...